AR SB176

Authorizes Arkansas pharmacists to test, screen, and treat eight specific health conditions within a written protocol framework: influenza, streptococcal pharyngitis, lice, skin conditions (ringworm, insect bites, athlete's foot), cold sores, allergic rhinitis, motion sickness, and antimalarial medications for travel.

Requires the Arkansas State Board of Pharmacy, in consultation with the Arkansas State Medical Board, to adopt rules establishing a formulary of FDA-approved medicinal drugs that pharmacists may prescribe for these conditions, excluding Schedule I-IV controlled substances.

Pharmacists performing these services must hold a valid pharmacy license, report influenza diagnoses to the Department of Health, provide patient records to designated healthcare practitioners upon request, and maintain patient records for two years.

Applies only to conditions for which the pharmacist has tested and received approval under the established protocol.

Effective date: January 1, 2022.